C-CAMP partners with Imperial College London, to launch the Indo-UK Life Sciences Innovation Corridor
Centre for Cellular and Molecular Platforms (C-CAMP) has signed an MoU with Imperial College London, to institute a cross-border innovation collaboration between India and the United Kingdom (UK) that will leverage mutual research and entrepreneurial ecosystems and deepen India-UK ties in the life sciences sector.
The Corridor aims to create and foster a long-term vision for greater bilateral innovation and a shared scope for exchange of talent such as researchers, innovators and startups. It will also be a medium for a formalised two-way knowledge and evidence sharing system with respect to priority challenge areas, innovation readiness and ecosystem initiatives that enable more problem-solving in mutually beneficial biology questions.
The partnership between Imperial and C-CAMP was signed by Professor Hugh Brady, President, Imperial College London and Dr Taslimarif Saiyed, Director-CEO, C-CAMP and announced at the C-CAMP premises in Bengaluru, India.
Welcoming the MoU, Prof. Brady said: “This ambitious partnership reflects Imperial’s deep commitment to strengthening long-term collaborations with India’s life sciences ecosystem. By joining forces with C-CAMP and supported through our Imperial Global India initiative, we are creating a powerful bridge between the UK and India that connects world-class research with entrepreneurship and translation. The Indo-UK Life Sciences Innovation Corridor will enable researchers, innovators, and startups to collaborate more effectively and accelerate new technologies to address global challenges.”
President Hugh Brady at C-CAMP in March 2025.
Dr. Saiyed echoed Prof Brady’s excitement on the agreement, saying, “The Indo UK Life Sciences Innovation Corridor marks a remarkable chapter of synergy between two of the world’s capital cities in biotech science and innovation, Bengaluru and London. We are envisioning the next era of Indo-British collaboration in the Biosciences, a core area of interest to both geographies and human society at large. The five-year long partnership is a strategic decision to provide an enduring platform to bring together the complementary strengths of both ecosystems in developing, validating and deploying globally relevant life sciences solutions.”
One of the novel initiatives of the Corridor on the cards is a bi-directional exchange mechanism for UK based teams to assess deployment-readiness in India and India-based teams to seek deployment avenues in UK and potentially Europe, due to contextual similarities.
The Corridor is also set to explore joint fundraising and partnership pathways to ensure sustainability and scalability of the programme for bringing positive change and lasting impact.
Last year Imperial launched Imperial Global India to drive high-impact science and technology programmes with academic, industrial and innovation partners, nurture a two-way flow of STEMB talent between the UK and India and support Imperial’s growing Indian alumni network. The liaison office in India’s tech capital Bengaluru creates a powerful hub and communications channel for Imperial to build on this strong foundation of collaboration.
